Novel Peptidyl α-Keto Amide Inhibitors of Calpains and Other Cysteine Proteases
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (20) , 4089-4098
- https://doi.org/10.1021/jm950541c
Abstract
A series of new dipeptidyl α-keto amides of the general structure R1-l-Leu-d,l-AA-CONH-R2 were synthesized and evaluated as inhibitors for the cysteine proteases calpain I, calpain II, and cathepsin B. They combine 10 different N-protecting groups (R1), 3 amino acids residues in P1 (AA), and 44 distinct substituents on the α-keto amide nitrogen (R2). In general, calpain II was more sensitive to these inhibitors than calpain I, with a large number of inhibitors displaying dissociation constants (Ki) in the 10−100 nM range. Calpain I was also effectively inhibited, but very low Ki values were observed with a smaller number of inhibitors than with calpain II. Cathepsin B was weakly inhibited by most compounds in this study. The best inhibitors for calpain II were Z-Leu-Abu-CONH-CH2-CHOH-C6H5 (Ki = 15 nM), Z-Leu-Abu-CONH-CH2-2-pyridyl (Ki = 17 nM), and Z-Leu-Abu-CONH-CH2-C6H3(3,5(OMe)2) (Ki = 22 nM). The best calpain I inhibitor in this study was Z-Leu-Nva-CONH-CH2-2-pyridyl (Ki = 19 nM). The peptide α-keto amide Z-Leu-Abu-CONH-(CH2)2-3-indolyl was the best inhibitor for cathepsin B (Ki = 31 nM). Some compounds acted as specific calpain inhibitors, with comparable activity on both calpains I and II and a lack of activity on cathepsin B (e.g., 40, 42, 48, 70). Others were specific inhibitors for calpain I (e.g., 73) or calpain II (e.g., 18, 19, 33, 35, 56). Such inhibitors may be useful in elucidating the physiological and pathological events involving these proteases and may become possible therapeutic agents.Keywords
This publication has 13 references indexed in Scilit:
- Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat.Proceedings of the National Academy of Sciences, 1996
- Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration.Stroke, 1994
- Stereospecific Synthesis of Peptidyl .alpha.-Keto Amides as Inhibitors of CalpainJournal of Medicinal Chemistry, 1994
- Postischemic Administration of AK275, a Calpain Inhibitor, Provides Substantial Protection against Focal Ischemic Brain DamageJournal of Cerebral Blood Flow & Metabolism, 1994
- Inactivation of calpain by peptidyl fluoromethyl ketonesJournal of Medicinal Chemistry, 1992
- A brief period of hypoxia causes proteolysis of cytoskeletal proteins in hippocampal slicesBrain Research, 1991
- .alpha.-Diketone and .alpha.-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinasesJournal of Medicinal Chemistry, 1990
- Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. I. Biochemical studiesBrain Research, 1988
- Synthetic applications of trimethylsilyl cyanide. Efficient synthesis of .beta.-aminomethyl alcoholsThe Journal of Organic Chemistry, 1974
- 1,3,7-Trisubstituted 8-isothiocyanatomethylxanthinesCollection of Czechoslovak Chemical Communications, 1970